Publications

Selected publications:

  1. Oikkonen J, Zhang K, Salminen L, Schulman I, Lavikka K, Andersson N, Ojanperä E, Hietanen S, Grénman S, Lehtonen R, Huhtinen K, Carpén O, Hynninen J, Färkkilä A, Hautaniemi S. Prospective longitudinal ctDNA workflow reveals clinically actionable alterations in ovarian cancer. JCO Precision Oncology, 2019 :3, 1-12.
  2. Alkodsi A, Cervera A, Zhang K, Louhimo R, Meriranta L, Pasanen A, Leivonen S-K, Holte H, Leppä S, Lehtonen R, Hautaniemi S. Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes. Leukemia (accepted).
  3. Cervera A, Rantanen V, Ovaska K, Laakso M, Nuñez-Fontarnau J, Alkodsi A, Casado J, Facciotto C, Häkkinen A, Louhimo R, Karinen S, Zhang K, Lavikka K, Lyly L, Singh MP, Hautaniemi S. Anduril 2: Upgraded large-scale data integration framework. Bioinformatics, 2019 [advanced access].
  4. Kozlowska E, Farkkila A, Vallius T, Carpen O, Kemppainen J, Grenman S, Lehtonen R, Hynninen J, Hietanen S, Hautaniemi S. Mathematical modeling predicts response to chemotherapy and drug combinations in ovarian cancer. Cancer Research, 2018, 78(14):4036-4044.
  5. Chen P, Huhtinen K, Kaipio K, Mikkonen P, Aittomäki V, Lindell R, Hynninen J, Auranen A, Grenman S, Lehtonen R, Carpén O, Hautaniemi S. Identification of prognostic groups in high-grade serous ovarian cancer treated with platinum-taxane chemotherapy. Cancer Research, 75(15):2987-98, 2015.

RSS Feed

No results.